- Home
- JZ vs XBIO Comparison
JZ vs XBIO Comparison
Compare JZ & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JZ
- XBIO
- Stock Information
- Founded
- JZ 2011
- XBIO N/A
- Country
- JZ China
- XBIO United States
- Employees
- JZ N/A
- XBIO N/A
- Industry
- JZ Other Consumer Services
- XBIO Biotechnology: Pharmaceutical Preparations
- Sector
- JZ Real Estate
- XBIO Health Care
- Exchange
- JZ Nasdaq
- XBIO Nasdaq
- Market Cap
- JZ 4.9M
- XBIO 5.9M
- IPO Year
- JZ 2022
- XBIO N/A
- Fundamental
- Price
- JZ $1.40
- XBIO $2.54
- Analyst Decision
- JZ
- XBIO Hold
- Analyst Count
- JZ 0
- XBIO 1
- Target Price
- JZ N/A
- XBIO N/A
- AVG Volume (30 Days)
- JZ 3.7K
- XBIO 72.1K
- Earning Date
- JZ 10-16-2025
- XBIO 11-13-2025
- Dividend Yield
- JZ N/A
- XBIO N/A
- EPS Growth
- JZ N/A
- XBIO N/A
- EPS
- JZ N/A
- XBIO N/A
- Revenue
- JZ $34,090,704.00
- XBIO $2,858,935.00
- Revenue This Year
- JZ N/A
- XBIO $1.99
- Revenue Next Year
- JZ N/A
- XBIO $20.00
- P/E Ratio
- JZ N/A
- XBIO N/A
- Revenue Growth
- JZ N/A
- XBIO 13.30
- 52 Week Low
- JZ $1.30
- XBIO $2.20
- 52 Week High
- JZ $14.60
- XBIO $13.93
- Technical
- Relative Strength Index (RSI)
- JZ 37.46
- XBIO 38.98
- Support Level
- JZ $1.38
- XBIO $2.51
- Resistance Level
- JZ $1.47
- XBIO $2.70
- Average True Range (ATR)
- JZ 0.04
- XBIO 0.20
- MACD
- JZ -0.01
- XBIO -0.04
- Stochastic Oscillator
- JZ 6.09
- XBIO 18.26
About JZ Jianzhi Education Technology Group Company Limited
Jianzhi Education Technology Group Co Ltd engages in developing educational content to fulfill the massive demand for high-quality, professional development training resources in China. The company and its subsidiaries VIE and VIEs generate subscription revenue through selling subscriptions to online learning platforms, higher education institutions, and other institutional customers under a B2B2C model mainly through the platform of Sentu Academy; offering subscriptions concerning educational content in mobile video packages directly to end users under a B2C model through the platforms such as Fish Learning or Light Class, etc. It has two operating segments: Educational content services and other services and IT-related solution services.
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.